Black Rock Inc. Cytokinetics Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Cytokinetics Inc stock. As of the latest transaction made, Black Rock Inc. holds 14,672,779 shares of CYTK stock, worth $537 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,672,779
Previous 12,414,773
18.19%
Holding current value
$537 Million
Previous $870 Million
8.67%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding CYTK
# of Institutions
406Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Vanguard Group Inc Valley Forge, PA11.8MShares$434 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$365 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$293 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$223 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.07MShares$113 Million4.32% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.45B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...